134 related articles for article (PubMed ID: 38130562)
1. The Use of Hospital Services by Patients With Muscle Invasive Bladder Cancer in the Last Year of Life: Identifying the Areas to Improve Care.
Matson M; Tien T; Yardy G; Allchorne P; Green JSA
Cureus; 2023 Nov; 15(11):e49175. PubMed ID: 38130562
[TBL] [Abstract][Full Text] [Related]
2. The Use of Healthcare Services by Prostate Cancer Patients in the Last 12 Months of Life: How Do We Improve the Quality of Care During This Period?
Tien T; Gkougkousis E; Allchorne P; Green JSA
J Palliat Care; 2021 Apr; 36(2):93-97. PubMed ID: 33241737
[TBL] [Abstract][Full Text] [Related]
3. Acute hospital-based services used by adults during the last year of life in New South Wales, Australia: a population-based retrospective cohort study.
Goldsbury DE; O'Connell DL; Girgis A; Wilkinson A; Phillips JL; Davidson PM; Ingham JM
BMC Health Serv Res; 2015 Dec; 15():537. PubMed ID: 26637373
[TBL] [Abstract][Full Text] [Related]
4. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
Busolo D; Woodgate R
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
[TBL] [Abstract][Full Text] [Related]
5. Hospital healthcare utilisation among older adults admitted to a university hospital in the last months of life: A retrospective observational study.
Ng TS; Lam CL; Ong T
Med J Malaysia; 2022 Sep; 77(5):585-589. PubMed ID: 36169070
[TBL] [Abstract][Full Text] [Related]
6. Health service utilisation during the last year of life: a prospective, longitudinal study of the pathways of patients with chronic kidney disease stages 3-5.
Chambers S; Healy H; Hoy WE; Kark A; Ratanjee S; Mitchell G; Douglas C; Yates P; Bonner A
BMC Palliat Care; 2018 Apr; 17(1):57. PubMed ID: 29622009
[TBL] [Abstract][Full Text] [Related]
7. Treatment Allocation and Survival in Patients Diagnosed with Nonmetastatic Muscle-invasive Bladder Cancer: An Analysis of a National Patient Cohort in England.
John JB; Varughese MA; Cooper N; Wong K; Hounsome L; Treece S; McGrath JS; Harden S
Eur Urol Focus; 2021 Mar; 7(2):359-365. PubMed ID: 32088138
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy Management of Muscle Invasive Bladder Cancer: Evaluation of a National Cohort.
Varughese M; Treece S; Drinkwater KJ
Clin Oncol (R Coll Radiol); 2019 Sep; 31(9):637-645. PubMed ID: 31122808
[TBL] [Abstract][Full Text] [Related]
9. The trajectory of patients who die from metastatic prostate cancer: a population-based study.
Collins A; Sundararajan V; Millar J; Burchell J; Le B; Krishnasamy M; McLachlan SA; Hudson P; Mileshkin L; Philip J
BJU Int; 2019 May; 123 Suppl 5():19-26. PubMed ID: 30371986
[TBL] [Abstract][Full Text] [Related]
10. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
Kim KH; You D; Jeong IG; Hong JH; Ahn H; Kim CS
Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
[TBL] [Abstract][Full Text] [Related]
11. Cost consequences of unscheduled emergency admissions in cancer patients in the last year of life.
McFerran E; Cairnduff V; Elder R; Gavin A; Lawler M
Support Care Cancer; 2023 Mar; 31(3):201. PubMed ID: 36869930
[TBL] [Abstract][Full Text] [Related]
12. The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis.
Bruins HM; Aben KK; Arends TJ; van der Heijden AG; Witjes AJ
Urol Oncol; 2016 Apr; 34(4):166.e1-6. PubMed ID: 26705102
[TBL] [Abstract][Full Text] [Related]
13. Quality indicators for the management of muscle-invasive bladder cancer in the perioperative setting of radical cystectomy: a narrative review.
König F; Pradere B; Grossmann NC; Quhal F; Rajwa P; Laukhtina E; Mori K; Katayama S; Yanagisawa T; Mostafai H; Motlagh RS; Aydh A; Dahlem R; Shariat SF; Rink M
Transl Cancer Res; 2022 Apr; 11(4):908-917. PubMed ID: 35571640
[TBL] [Abstract][Full Text] [Related]
14. The role of palliative radiotherapy in the management of elderly and frail patients with advanced bladder cancer: A survey by the AIRO uro-group.
Marvaso G; Nicosia L; Vinciguerra A; Borghetti P; Trodella LE; Francolini G; Timon G; Matrone F; Ognibene L; Franzese C; Jereczek-Fossa BA; Arcangeli S
Med Oncol; 2021 Jan; 38(2):14. PubMed ID: 33484363
[TBL] [Abstract][Full Text] [Related]
15. Assessment of quality of life, information, and supportive care needs in patients with muscle and non-muscle invasive bladder cancer across the illness trajectory.
Chung J; Kulkarni GS; Morash R; Matthew A; Papadakos J; Breau RH; Guttman D; Bender J; Jones JM
Support Care Cancer; 2019 Oct; 27(10):3877-3885. PubMed ID: 30767131
[TBL] [Abstract][Full Text] [Related]
16. The impact of community-based palliative care on acute hospital use in the last year of life is modified by time to death, age and underlying cause of death. A population-based retrospective cohort study.
Spilsbury K; Rosenwax L; Arendts G; Semmens JB
PLoS One; 2017; 12(9):e0185275. PubMed ID: 28934324
[TBL] [Abstract][Full Text] [Related]
17. Primary versus secondary muscle-invasive bladder cancer: survival after curative treatment.
Møller CT; Fosså SD; Tafjord G; Babigumira R; Berge V; Andreassen BK
Scand J Urol; 2022 Jun; 56(3):214-220. PubMed ID: 35506475
[TBL] [Abstract][Full Text] [Related]
18. The utilization of palliative care in gynecologic oncology patients near the end of life.
Fauci J; Schneider K; Walters C; Boone J; Whitworth J; Killian E; Straughn JM
Gynecol Oncol; 2012 Oct; 127(1):175-9. PubMed ID: 22735789
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
